Bartlett & Co. LLC Vista Gen Therapeutics, Inc. Transaction History

Bartlett & Co. LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Jul 31, 2018	SELL	$0.85 - $1.5 $12,750 - $22,500	-15,000 Closed	0 $0
Q4 2017 Jan 19, 2018	BUY	$0.72 - $2.03 $3,600 - $10,149	5,000 Added 50.0%	15,000 $17,000
Q3 2017 Oct 23, 2017	BUY	$1.54 - $1.85 $15,400 - $18,500	10,000	10,000 $16,000

2.7M

Ticker VTGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 206,836,000
Market Cap $623M
Description
VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing various medicines with the potential to care for anxiety, depression, and other disorders of the central nervous system (CNS). The company's CNS pipeline includes PH94B, a rapid-onset neuroactive nasal spray, which is in Phase III d...

Get notified when there are updates to the investment portfolio of Bartlett & Co. LLC, based on Form 13F filings with the SEC.

Stay updated on Bartlett & Co. LLC with notifications on news.